Anthocyanidins inhibit activator protein 1 activity and cell transformation: Structure-activity relationship and molecular mechanisms

Carcinogenesis

Volumn 25, Issue 1, 2004, Pages 29-36

  Hou, De Xing ^a   Kai, Keiko ^e   Li, Jian Jian ^b   Lin, Shigang ^a   Terahara, Norihiko ^c   Wakamatsu, Mika ^a   Fujii, Makoto ^a   Young, Mattew R ^d   Colburn, Nancy ^d  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MINAMI KYUSHU UNIVERSITY   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTHOCYANIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; CATECHOL; CYANIDIN; DELPHINIDIN; MALVIDIN CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PELARGONIDIN; PEONIDIN; PETUNIDIN CHLORIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR PROMOTION;

ANIMALS; ANTHOCYANINS; ANTHRACENES; ANTICARCINOGENIC AGENTS; BUTADIENES; CELL TRANSFORMATION, NEOPLASTIC; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHORYLATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 1642422882     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg184     Document Type: Article

References (70)

1. Harborne,J.B. and Grayer,R.J. (1998) The anthocyanins. In Harborne,J.B. ed., The Flavonoids. Chapman and Hall, London, UK, pp. 1-20.
2. Mazza,G. (1995) Anthocyanins in grapes and grape products. Crit. Rev. Food Sci. Nutr., 35, 341-371.
3. Kuhnau,J. (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet, 24, 117-191.
4. Tsuda,T., Horio,F. and Osawa,T. (1999) Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett., 449, 179-182.
5. Miyazawa,T., Nakagawa,K., Kudo,M., Muraishi,K. and Someya,K. (1999) Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J. Agric. Food Chem., 47, 1083-1091.
6. Matsumoto,H., Inaba,H., Kishi,M., Tominaga,S., Hirayama,M. and Tsuda,T. (2001) Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem., 49, 1546-1551.
7. Renaud,S. and de Logeril,M. (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
8. Muth,E.R., Laurent,J.M. and Jasper,P. (2000) The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern. Med. Rev., 5, 164-173.
9. Wang,H., Cao,G. and Prior,R.L. (1997) Oxygen radical absorbing capacity of anthocyanins. J. Agric. Food Chem., 45, 304-309.
10. Wang,H., Nair,M.G., Strasburg,G.M., Chang,Y.-C., Booren,A.M., Gray,J.I. and DeWitt,D.L. (1999) Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J. Nat. Prod., 64, 294-296.
11. Tsuda,T., Horio,F. and Osawa,T. (2000) The role of anthocyanins as an antioxidant under oxidative stress in rats. Biofactors, 13, 133-139.
12. Tsuda,T., Shiga,K., Ohshima,K., Kawakishi,S. and Osawa,T. (1996) Inhibition of lipid peroxidation and the active oxygen radical scavenging effect of anthocyanin pigments isolated from Phaseolus vulgaris L. Biochem Pharmacol., 52, 1033-1039.
13. Tsuda,T., Horio,F. and Osawa,T. (1998) Dietary cyanidin 3-O-beta-D-glucoside increases ex vivo oxidation resistance of serum in rats. Lipids, 33, 583-588.
14. Omenn,G.S. (1995) What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart diseases. Ann. Epidemiol., 5, 333-335.
15. Kamei,H., Kojima,T., Hasegawa,M., Koide,T., Umeda,T., Yukawa,T. and Terabe,K. (1995) Suppression of tumor cell growth by anthocyanins in vitro. Cancer Invest., 13, 590-594.
16. Nagase,H., Sasaki,K., Kito,H., Haga,A. and Sato,T. (1998) Inhibitory effect of delphinidin from Solanum melongena on human fibrosarcoma HT-1080 invasiveness in vitro. Planta Med., 64, 216-219.
17. Meiers,S., Kemeny,M., Weyand,U., Gastpar,R., von Angerer,E. and Marko,D. (2001) The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. J. Agric. Food Chem., 49, 958-964.
18. Bomser,J., Madhavi,D.L., Singletary,K. and Smith,M.A. (1996) In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med., 64, 212-216.
19. Bomser,J.A., Singletary,K.W., Wallig,M.A. and Smith,M.A. (1999) Inhibition of TPA-induced tumor promotion in CD-1 mouse epidermis by a polyphenolic fraction from grape seeds. Cancer Lett., 135, 151-157.
20. Hagiwara,A., Yoshino,H., Ichihara,T., Kawabe,M., Tamano,S., Aoki,H., Koda,T., Nakamura,M., Imaida,K., Ito,N. and Shirai,T. (2002) Prevention by natural food anthocyanins, pupple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J. Toxicol. Sci., 27, 57-68.
21. Brown,K. and Balmain,A. (1995) Transgenic mice and squamous multistage skin carcinogenesis. Cancer Metastasis Rev., 14, 113-124.
22. Hong,W.K. and Sporn,M.B. (1997) Recent advances in chemoprevention of cancer. Science, 278, 1073-1077.
23. Hsu,T.C., Young,M.R., Cmarik,J. and Colburn,N.H. (2000) Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med., 28, 1338-1348.
24. Angel,P. and Karin,M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
25. Dong,Z., Birrer,M.J., Watts,R.G., Matrisian,L.M. and Colburn,N.H. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA, 91, 609-613.
26. Huang,C., Ma,W.Y., Young,M.R., Colburn,N.H. and Dong,Z. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA, 95, 156-161.
27. Sawai,H., Okazaki,T., Yamamoto,H. et al. (1995) Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem., 270, 27326-27331.
28. Colburn,N.H., Former,B.F., Nelson,K.A. and Yuspa,S.H. (1979) Tumour promoter induces anchorage independence irreversibly. Nature, 281, 589-591.
29. Adler,V., Pincus,M.R., Polotskaya,A., Montano,X., Friedman,F.K. and Ronai,Z. (1996) Activation of c-Jun-NH2-kinase by UV irradiation is dependent on p21ras. J. Biol. Chem., 271, 23304-23309.
30. Lamb,R.F., Hennigan,R.F., Turnbull,K., Katsanakis,K.D., MacKenzie,E.D., Birnie,G.D. and Ozanne,B.W. (1997) AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol., 17, 965-976.
31. Pinkus,R., Weiner,L.M. and Daniel,V. (1996) Role of oxidants and antioxidants in the induction of AP-1, NF-κB and glutathione S-transferase gene expression. J. Biol. Chem., 271, 13422-13429.
32. Saez,E., Rutberg,S.E., Mueller,E., Oppenheim,H., Smoluk,J., Yuspa,S.H. and Spiegelman,B.M. (1995) c-Fos is required for malignant progression of skin tumors. Cell, 82, 721-732.
33. Dong,Z., Crawford,H.C., Lavrovsky,V., Taub,D., Watts,R., Matrisian,L.M. and Colburn,N.H. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylpborbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinogen., 19, 204-212.
34. Risse-Hackl,G., Adamkiewicz,J., Wimmel,A. and Schuermann,M. (1998) Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene, 16, 3057-3068.
35. Dumont,J.A., Bitonti,A.J., Wallace,C.D., Baumann,R.J., Cashman,E.A. and Cross-Doersen,D.E. (1996) Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ., 7, 351-359.
36. Young,M.R., Li,J.J., Rincon,M., Flavell,R.A., Sathyanarayana,B.K., Hunziker,R. and Colburn,N.H. (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl Acad. Sci. USA, 96, 9827-9832.
37. Chen,N., Nomura,M., She,Q.B., Ma,W.Y., Bode,A.M., Wang,L., Flavell,R.A. and Dong,Z. (2001) Suppression of skin tumorigenesis in c-Jun NH (2)-terminal kinase-2-deficient mice. Cancer Res., 61, 3908-3912.
38. Li,J.J., Rhim,J.S., Schlegel,R., Vousden,K.H. and Colburn,N.H. (1998) Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene, 16, 2711-2721.
39. Li,J.J., Cao,Y., Young,M.R. and Colburn,N.H. (2000) Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol. Carcinogen., 29, 159-169.
40. Li,J.J., Dong,Z., Dawson,M.I. and Colburn,N.H. (1996) Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res., 56, 483-489.
41. Li,J.J., Westergaard,C., Ghosh,P. and Colburn,N.H. (1997) Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57, 3569-3576.
42. Dong,Z., Ma,W., Huang,C. and Yang,C.S. (1997) Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Cancer Res., 57, 4414-4419.
43. Chung,J. Y., Huang,C., Meng,X., Dong,Z. and Yang,C.S. (1999) Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res., 59, 4610-4617.
44. Liu,G., Bode,A., Ma,W.Y., Sang,S., Ho,C.T. and Dong,Z. (2001) Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res., 61, 5749-5756.
45. Andersen,M., Opheim,S., Aksnes,D.W. and Froystein,N.A. (1991) Structure of petanin, an acylated anthocyanin isolated from Solanum tuberosum, using homo-nuclear and hetero-nuclear 2-dimensional nuclear magnetic resonance techniques. Phytochem. Anal., 2, 230-236.
46. Lin,S., Li,J.J., Fujii,M. and Hou,D.-X. (2003) Rhein inhibits TPA-induced activator protein activation and cell transformation by blocking the JNK-dependent pathway. Int. J. Oncol., 22, 829-833.
47. Hou,D.-X., Fukuda,M., Fujii,M. and Fuke,Y. (2000) Transcriptional regulation of nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase in murine hepatoma cells by 6-(methylsufinyl)hexyl isothiocyanate, an active principle of wasabi (Eutrema wasabi Maxim). Cancer Lett., 161, 195-200.
48. Hou,D.-X., Fukuda,M., Johnson,J.A., Miyamori,K., Ushikai,M. and Fujii, M. (2001) Fisetin induces transcription of NADPH: quinone oxidoreductase gene through an antioxidant responsive element-involved activation. Int. J. Oncol., 18, 1175-1179.
49. Momparler,R.L. (1980) In vitro systems for evaluation of combination chemotherapy. Pharmacol. Ther., 8, 21-35.
50. De Benedetti,F., Falk,L., Ruscetti,F.W., Colburn,N.H., Faltynek,C.R. and Oppenheim,J.J. (1991) Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid. Cancer Res., 51, 1158-1164.
51. Dong,Z., Lavrovsky,V. and Colburn,N.H. (1995) Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis, 16, 749-756.
52. Karin,M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270, 16483-16486.
53. Young,M.R., Nair,R., Bucheimer,N., Tulsian,P., Brown,N., Chapp,C., Hsu,T.C. and Colburn,N.H. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol., 2, 587-598.
54. Macdonald,S.G., Crews,C.M., Wu,L., Driller,J., Clark,R., Erikson,R.L. and McCormick,F. (1993) Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol. Cell. Biol., 13, 6615-6640.
55. Dhanasekaran,N. and Premkumar Reddy,E. (1998) Signaling by dual sepecificity kinases. Oncogene, 17, 1447-1455.
56. Kolch,W. (2000) Meaningful relationship: the regulation of the Ras/Raf/MEK/ERK/ pathway by protein interactions. Biochem. J., 351, 289-305.
57. Sanchez,I., Hughes,R.T., Mayer,B.J., Yee,K., Woodgett,J.R., Avruch,J., Kyriakis,J.M. and Zon,L.I. (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature, 372, 794-798.
58. Derijard,B., Raingeaud,J., Barrett,T., Wu,I.H., Han,J., Ulevitch,R.J. and Davis,R.J. (1995) Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science, 267, 682-685.
59. Lin,A., Minden,A., Martinetto,H., Claret,F.X., Lange-Carter,C., Mercurio,F., Johnson,G.L. and Karin,M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science, 268, 286-290.
60. Favata,M.F., Horiuchi,K.Y., Manos,E.J. et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem., 273, 18643-18652.
61. Bennett,B.L., Sasaki,D.T., Murray,B.W. et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA, 98, 13681-13686.
62. Nakamura,Y., Colburn,N.H. and Gindhart,T.D. (1985) Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB6 cells by TPA. Carcinogenesis, 64, 229-235.
63. Nakamura,Y., Gindhart,T.D., Winterstein,D., Tomita,I., Seed,J.L. and Colburn,N.H. (1988) Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis, 9, 203-207.
64. Huang,C., Ma,W.Y., Li,J., Goranson,A. and Dong,Z. (1999) Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J. Biol. Chem., 274, 14595-14601.
65. Huang,C., Li,J., Ma,W.Y. and Dong,Z. (1999) JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem., 274, 29672-29676.
66. Watts,R.G., Huang,C., Young,M.R., Li,J-J., Dong,Z., Pennie,W.D. and Colburn,N.H. (1998) Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene, 17, 3493-3498.
67. Cano,E. and Mahadevan,L.C. (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci., 20, 117-122.
68. Kyriakis,J.M. and Avruch,J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev., 81, 807-869.
69. Zhao,Y., Xue,Y., Oberley,T.D., Kiningham,K.K., Lin,S.M., Yen,H.C., Majima,H., Hines,J. and St Clair,D. (2001) Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res., 61, 6082-6088.
70. Noda,Y., Kaneyuki,T., Mori,A. and Packer,L. (2002) Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin and pelargonidin. J. Agric. Food Chem., 50, 166-171.